Cerebras vs. SoundHound: Which AI Tech Stock Is a Better Buy in 2026?

Cerebras generated FY2025 revenue of about $510 million, up 76%, and swung to roughly $239 million of net income from a $482 million loss, though free cash flow remained negative at $393 million and its valuation is steep at 68.8x sales and 217x forward earnings. SoundHound's FY2025 revenue nearly doubled to $168.9 million, with its net loss narrowing to about $14 million from $351 million; it trades at a lower 12.4x sales multiple but is expected to remain loss-making with negative free cash flow. The article favors Cerebras for its AI-infrastructure growth potential, citing consensus sales estimates of $888 million in 2026, $3 billion in 2027 and $7.5 billion in 2028, while highlighting substantial execution, competition, concentration and valuation risks.

Analysis

CBRS is being valued as if its architecture can convert a handful of hyperscale/strategic deployments into a repeatable platform business. The critical issue is not reported earnings but cash conversion: persistent capital intensity and working-capital consumption would make any revenue concentration problem materially more dangerous, particularly if one large customer defers an expansion cycle. Consensus implies an exceptionally steep multi-year revenue ramp; even modest slippage in deployment timing, yield economics, or cloud-channel demand would drive both estimate cuts and multiple compression from an already demanding base.

SOUN has a more defensible near-term balance-sheet runway, but its product category is vulnerable to feature commoditization by GOOG, AMZN, MSFT and AAPL. Its acquisition-led model creates a 1-3 quarter integration test: cross-sell conversion and retention must improve faster than stock-based compensation, integration expense, and cash burn. The non-obvious upside is that enterprise voice deployments can become embedded workflow infrastructure with high switching friction; the downside is that large customers increasingly demand bundled AI functionality, shifting pricing power to cloud vendors.

Near term, neither name offers a clean broad-AI beta trade: CBRS is an execution-duration asset, while SOUN is a post-acquisition proof-of-synergy asset. The contrarian view is that SOUN's lower sales multiple does not automatically mean lower risk—its addressable market may be less protected—while CBRS's premium can persist only if independent evidence confirms scalable unit economics rather than a concentrated-contract revenue step-up.

Key Decisions for Investors

• Do not initiate a core CBRS long before the next earnings release; require disclosure or corroboration of customer concentration, backlog conversion, gross-margin trajectory, and cash-capex needs. A revenue-guide miss or free-cash-flow deterioration would invalidate the high-duration thesis and could produce a disproportionate de-rating over 1-3 months.
• Use CBRS as a tactical short/watch candidate only after a material rally and if borrow is available; pair against long NVDA rather than a naked semiconductor short. The thesis is relative multiple compression if CBRS deployment economics disappoint, but size small given customer-announcement and short-squeeze risk.
• Keep SOUN on an integration watchlist rather than adding on revenue growth alone. Upgrade to a tactical long only if the next two quarters show improving net revenue retention, measurable cross-sell from acquired assets, and a declining cash-burn rate; failure to show those metrics would favor avoiding or shorting rallies.
• For diversified AI exposure, prefer AMZN or MSFT over either single-name speculative position for the next 6-18 months: both monetize enterprise AI demand through existing distribution and can capture voice/agent workloads even if standalone application vendors lose pricing power.